Targeting therapy-induced senescence across multiple breast cancer subtypes in a metastatic bone-like microenvironment

Chemotherapeutic treatment of breast cancer with Doxorubicin (DOX) can induce tumor and stromal cell senescence leading to therapy-resistance. Senescence-associated secretory phenotype (SASP) promotes secretion of pro-inflammatory and tumorigenic factors causing systemic inflammation. Combined, this can …

34 Early
Design 5
Sample 7
Peer Review 4
Replication 6
Transparency 12

A Drug That Kills Aging Cells in Osteoarthritis Without Harming Healthy Ones

A candidate drug could selectively kill harmful aged cells in arthritic joints while protecting healthy ones—potentially opening a new treatment avenue.

Researchers found that mocetinostat, a drug that inhibits certain histone deacetylases, selectively kills senescent (aged) chondrocytes—cells that accumulate in arthritic joints—while leaving healthy cells intact. This discovery could lead to a new class of "senolytic" …

40 Early
Design 5
Sample 6
Peer Review 15
Replication 5
Transparency 9

Why Aging Cells Sometimes Help—and Sometimes Hurt—Muscle Repair

Understanding how aging cells block muscle repair could lead to new treatments to help older adults stay strong and independent.

This review examines cellular senescence (aging cells that stop dividing) in muscle regeneration, finding that senescent cells play a dual role: they can briefly help repair muscle after injury, but when they accumulate in aging …

37 Early
Design 4
Sample 2
Peer Review 15
Replication 7
Transparency 9

Why centenarians' immune systems stay young

Learning how 100+ year-olds keep strong immune systems could help us stay healthier longer.

Researchers reviewed how people who live to 100+ maintain surprisingly youthful immune function despite extreme age, resisting the chronic inflammation and immune decline that typically accompany aging. They identified several biological mechanisms—including controlled inflammatory pathways, …

51 Promising
Design 4
Sample 8
Peer Review 18
Replication 10
Transparency 11

How immune cells called NK cells shape healthy aging

This review synthesizes evidence that natural killer (NK) cells—a type of immune cell—undergo age-related changes that impair their ability to clear damaged cells and regulate inflammation, contributing to aging-related diseases. The authors propose NK cell …

35 Early
Design 4
Sample 2
Peer Review 11
Replication 9
Transparency 9

Cutting dietary valine extends male mouse lifespan by 23%

One amino acid in protein might extend male lifespan; needs human testing to know if it matters for you.

Researchers found that lifelong restriction of valine, a branched-chain amino acid in protein, improved metabolic health and reduced aging markers in both male and female mice, but only extended lifespan in males by 23%. The …

31 Early
Design 6
Sample 10
Peer Review 3
Replication 5
Transparency 7

Immunosenescence in Human Disease: Mechanistic Insights and Therapeutic Opportunities.

Immunosenescence, an age-associated decline in immune function, is increasingly recognized as a central determinant of health and disease in older adults. Characterized by thymic involution, loss of naïve T cells, contraction of T cell receptor …

38 Early
Design 5
Sample 7
Peer Review 10
Replication 6
Transparency 10

Eugenol from Syzygium aromaticum enhances longevity and proteostasis in aged yeast.

Clove (Syzygium aromaticum) extracts promote longevity in several model systems, yet the underlying molecular mechanisms responsible for the pro-longevity remain poorly defined. This study utilized a Saccharomyces cerevisiae model to investigate how clove extracts modulate …

44 Early
Design 5
Sample 7
Peer Review 16
Replication 6
Transparency 10

Can senolytic drugs restore fertility in female mice with fatty liver disease?

Researchers treated female mice with fatty liver disease (MASLD) using senolytic drugs—compounds that eliminate senescent (aged) cells—and found pregnancy rates improved, particularly through reduced aging and inflammation in the ovaries. However, the treatment had limited …

39 Early
Design 6
Sample 6
Peer Review 13
Replication 5
Transparency 9

A role for autophagy of the ER in rejuvenation revealed by microfluidics-based lifespan profiling of yeast gametes

During mitotic growth, Saccharomyces cerevisiae cells age by dividing asymmetrically producing young daughter cells while retaining age-associated damage in the mother cell, which will eventually become senescent. Gametogenesis naturally and completely resets precursor cell lifespan, …

34 Early
Design 5
Sample 7
Peer Review 4
Replication 6
Transparency 12

Keeping Cells Fit in Old Age by Rewiring a Key Metabolic Switch

Researchers found a way to keep old cells working well by tweaking one metabolic switch, suggesting aging loss of fitness isn't inevitable.

Researchers found that activating a protein called AMPK can prevent aging-related fitness decline in yeast cells, but only if you also prevent it from shutting down fat production—a dual problem that a specially engineered AMPK …

30 Early
Design 6
Sample 7
Peer Review 3
Replication 5
Transparency 9

Cytomegalovirus serostatus and plasma MCP-1 levels are associated with antibody response to seasonal influenza vaccine across age and sex

BackgroundWhile immunologic aging impacts immune responses to vaccination, consistent biomarkers associated with aging of the immune system and suboptimal serologic response to influenza vaccination have not been well-studied. Identification of readily measurable biomarkers of immunosenescence …

34 Early
Design 5
Sample 7
Peer Review 4
Replication 6
Transparency 12

How aging immune systems damage lungs—and what treatments might help

If your immune system ages slower, your lungs might stay healthier longer—but we need better treatments to prove it works.

This review examines how immunosenescence (age-related immune decline) drives lung diseases like COPD, fibrosis, and cancer, and surveys emerging treatments including senolytics, stem cell therapy, and lifestyle interventions. While it synthesizes current knowledge well, it's …

36 Early
Design 4
Sample 2
Peer Review 13
Replication 7
Transparency 10

Can we reverse aging by partially reprogramming cells?

This review examines 'partial reprogramming'—a technique that temporarily activates rejuvenation factors to reverse aging hallmarks in cells and tissues without turning them into cancer-prone stem cells. Early evidence suggests it can restore tissue function and …

36 Early
Design 4
Sample 2
Peer Review 13
Replication 7
Transparency 10

Universal transcriptomic hallmarks of mammalian ageing and mortality.

Ageing and interventions modulate health and mortality1, yet the underlying molecular mechanisms of this modulation remain unclear. Here we integrate more than 11,000 transcriptomes from more than 25 tissues across 4 mammals (mouse, rat, macaque …

47 Early
Design 5
Sample 7
Peer Review 19
Replication 6
Transparency 10

New hydrogel with stem cell vesicles reverses aging damage in bone healing

Researchers created a gel that helps aging bones heal better by reducing inflammation and protecting stem cells from aging damage.

Researchers created a gel containing special vesicles from stem cells that reduces inflammation and cellular aging in aging bone, significantly improving bone and tendon healing in an osteoporosis model. This demonstrates a novel 'senomorphic' approach—directly …

42 Early
Design 6
Sample 6
Peer Review 16
Replication 5
Transparency 9

The Ess1 prolyl isomerase represses TERRA transcription and promotes telomere replication in Saccharomyces cerevisiae.

The conserved Ess1 prolyl isomerase (PIN1 in human) binds the carboxy-terminal domain (CTD) of RNA Pol II, and plays multiple roles in transcription regulation. Consistent with an essential role of the human PIN1 in telomere …

46 Early
Design 5
Sample 7
Peer Review 18
Replication 6
Transparency 10

Popular Senolytic Drugs Failed to Work in Rigorous Independent Testing

Drugs once thought to slow aging didn't work in independent tests—be cautious about anti-aging claims until proven by multiple labs.

Researchers from multiple labs independently tested two widely-publicized senolytic drugs (a GLS1 inhibitor and anti-PD-1 antibody) and found they did not reduce senescent cells or improve aging in mice—contradicting earlier claims. This highlights a serious …

60 Promising
Design 11
Sample 10
Peer Review 15
Replication 13
Transparency 11

Rethinking senescent cells: When to stop them, when to keep them

Some aging cells help your body work properly; new strategies could clear harmful ones while keeping helpful ones.

This review challenges the assumption that senescent cells are always harmful, showing that some actually support healthy aging through wound healing and tissue maintenance. The authors propose a new strategy: prevent bad senescence while selectively …

37 Early
Design 4
Sample 2
Peer Review 13
Replication 9
Transparency 9

How Lysosomes Control Aging: New Pathways to Longer, Healthier Lives

Cells have recycling centers that control aging. Better recycling may slow getting older and prevent age-related diseases.

This review examines how lysosomes—cellular recycling centers—actively regulate aging through two newly discovered signaling pathways (lysosomal surveillance response and transgenerational lysosomal signaling) and the protein TFEB. These findings suggest targeting lysosomal activity could be a …

35 Early
Design 4
Sample 2
Peer Review 13
Replication 6
Transparency 10